Trupanion, Inc. (NASDAQ:TRUP) Shares Bought by Hosking Partners LLP

Key Points

• Hosking Partners LLP increased its stake in Trupanion, Inc. by 86.9%, owning approximately $14.82 million worth of shares as of the latest SEC filing.
• Recent insider trading activity saw both COO John R. Gallagher and CEO Margaret Tooth sell 4,000 shares each, indicating a decrease in ownership for both executives.
• Wall Street analysts have a consensus rating of "Moderate Buy" for Trupanion, with an average price target of $55.60, following several changes to price targets by multiple firms.

Hosking Partners LLP lifted its holdings in Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 86.9% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 397,656 shares of the financial services provider's stock after acquiring an additional 184,936 shares during the period. Hosking Partners LLP owned 0.93% of Trupanion worth $14,821,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in TRUP. Palisade Capital Management LP raised its position in Trupanion by 36.7% during the first quarter. Palisade Capital Management LP now owns 244,354 shares of the financial services provider's stock valued at $9,107,000 after purchasing an additional 65,653 shares during the period. Dimensional Fund Advisors LP raised its position in Trupanion by 112.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 273,910 shares of the financial services provider's stock valued at $13,204,000 after purchasing an additional 144,828 shares during the period. Northern Trust Corp raised its position in Trupanion by 9.0% during the fourth quarter. Northern Trust Corp now owns 368,236 shares of the financial services provider's stock valued at $17,749,000 after purchasing an additional 30,549 shares during the period. Balyasny Asset Management L.P. raised its position in Trupanion by 368.2% during the fourth quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider's stock valued at $40,548,000 after purchasing an additional 661,559 shares during the period. Finally, American Century Companies Inc. purchased a new stake in Trupanion during the fourth quarter valued at approximately $1,111,000.

Trupanion Trading Up 2.4%

Shares of NASDAQ TRUP traded up $1.17 during midday trading on Tuesday, hitting $50.66. The company's stock had a trading volume of 578,992 shares, compared to its average volume of 606,908. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.32. The business's 50 day moving average is $51.16 and its two-hundred day moving average is $43.98. Trupanion, Inc. has a 12-month low of $31.00 and a 12-month high of $57.90. The firm has a market cap of $2.18 billion, a P/E ratio of 194.85 and a beta of 1.78.

Trupanion (NASDAQ:TRUP - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The financial services provider reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.03) by $0.25. Trupanion had a return on equity of 3.31% and a net margin of 0.81%. The company had revenue of $353.56 million for the quarter, compared to analysts' expectations of $346.73 million. During the same quarter in the prior year, the firm earned ($0.14) earnings per share. Trupanion's revenue was up 12.3% compared to the same quarter last year. As a group, equities research analysts expect that Trupanion, Inc. will post 0.13 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on TRUP shares. Stifel Nicolaus upped their price objective on Trupanion from $41.00 to $45.00 and gave the company a "hold" rating in a research report on Friday. Piper Sandler set a $67.00 price objective on Trupanion and gave the company an "overweight" rating in a research report on Friday. Lake Street Capital reduced their price target on Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a report on Friday, May 2nd. Finally, Cantor Fitzgerald started coverage on Trupanion in a report on Tuesday. They issued a "neutral" rating on the stock. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $55.60.

Insider Buying and Selling

In related news, CEO Margaret Tooth sold 4,000 shares of the stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $45.86, for a total value of $183,440.00. Following the transaction, the chief executive officer owned 118,784 shares of the company's stock, valued at $5,447,434.24. This represents a 3.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Fawwad Qureshi sold 2,534 shares of the stock in a transaction that occurred on Thursday, May 29th. The stock was sold at an average price of $48.31, for a total value of $122,417.54. Following the completion of the transaction, the chief financial officer directly owned 3,545 shares in the company, valued at approximately $171,258.95. This trade represents a 41.68% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 11,562 shares of company stock valued at $544,870 over the last quarter. 5.42% of the stock is owned by corporate insiders.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.